SCHEMBL30666269

SCHEMBL30666269

CC(C)(C)OC(=O)N1CC2(CC(c3sc4nnc(Cl)cc4c3C3CC3)C2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OXTR P30559 1/20 0.42
▸ AVPR1A P37288 1/20 0.42
▸ EHMT2 Q96KQ7 1/20 0.37
▸ KRAS P01116 1/20 0.35
▸ ACACB O00763 2/20 0.34
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ SCD5 Q86SK9 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ NSD2 O96028 1/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26683430 1.00 OXTR (0.42) OXTRAVPR1AEHMT2KRASACACB
SCHEMBL26683610 0.88 OXTR (0.43) OXTRAVPR1AEHMT2KRASACACB
SCHEMBL26683384 0.85 OXTR (0.39) OXTRAVPR1AEHMT2MEN1KMT2A
SCHEMBL30666275 0.85 OXTR (0.39) OXTRAVPR1AEHMT2MEN1KMT2A
SCHEMBL26683319 0.83 SMARCA2 (0.45) OXTRAVPR1AEHMT2KRASSCD5
SCHEMBL30666273 0.79 OXTR (0.45) OXTRAVPR1AEHMT2KRASACACB
SCHEMBL26683651 0.79 OXTR (0.45) OXTRAVPR1AEHMT2KRASACACB
SCHEMBL30666276 0.75 MAPT (0.44) MEN1KMT2ANPSR1TP53POLB
SCHEMBL26683361 0.75 MAPT (0.44) MEN1KMT2ANPSR1TP53POLB
SCHEMBL26683423 0.75 MAPT (0.43) MEN1KMT2ANPSR1TP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522277-A1 PYRAZINE DERIVATIVES AND USES THEREOF Foghorn Therapeutics Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220137-A1 PYRAZINE DERIVATIVES AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2023-11-16 — — WO disclosed
Send feedback